According to IMARC Group’s latest report, titled “Superdisintegrants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026.’ the global superdisintegrants market reached a value of US$ XX Million in 2020. Superdisintegrants are disintegrating agents that are used in the formulation of tablets and capsules. They help in the disintegration of compacted mass into primary particles while facilitating the release of active ingredients in a fluid environment. Superdisintegrants are extensively deployed for improving the absorption of the drug and treating various cardiovascular, infectious, neurological, inflammatory, hematological, and gastronomical ailments. At present, these are available in various types, including sodium starch glycolate, sago starch and croscarmellose.
Request for a PDF sample of this report: https://www.imarcgroup.com/superdisintegrants-market/requestsample
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The widespread product adoption to treat pediatric patients and the geriatric population, which is unable to swallow solid forms of medication, is primarily driving the global superdisintegrants market. Furthermore, the increasing demand for novel drugs amongst consumers is propelling the market growth. Moreover, the rising inclination of consumers toward natural drugs and medication is catalyzing the market growth. Other factors, such as the escalating prevalence of neurological disorders and the increasing usage of telemedicine, on account of the COVID-19 outbreak, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.
- Asahi Kasei Corporation
- Ashland Global Specialty Chemicals Inc.
- Avantor Inc.
- BASF SE
- Corel Pharma Chem
- DFE Pharma GmbH & Co. KG
- DuPont de Nemours Inc.
- JRS Pharma GmbH & Co. KG
- Merck KGaA
- Nippon Soda Co. Ltd.
- Roquette Frères
- Sigachi Industries Limited.
Key Market Segmentation:
Breakup by Product:
- Croscarmellose Sodium
- Sodium Starch Glycolate
- Ion Exchange Resin
- Modified Cellulose
Breakup by Type:
- Natural Superdisintegrant
- Synthetic Superdisintegrant
Breakup by Dosage Form:
- Tablets and Capsules
- Mouth-Dissolving Films
Breakup by Therapeutic Areas:
Breakup by Region:
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/superdisintegrants-market
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Market Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800